Ibom VK - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.

Talbot J, Ibom VK, Rizzieri DA, Barrier R, Niedzwieki D, DeCastro CM, Moore JO, Buckley P, Laney R, Stevenson D, Rumbaugh H, Gockerman JP. Talbot J, et al. Among authors: ibom vk. Clin Lymphoma. 2004 Sep;5(2):116-22. doi: 10.3816/clm.2004.n.018. Clin Lymphoma. 2004. PMID: 15453927

Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.

Rizzieri DA, Ibom VK, Moore JO, DeCastro CM, Rosner GL, Adams DJ, Foster T, Payne N, Thompson M, Vredenburgh JJ, Gasparetto C, Long GD, Chao NJ, Gockerman JP. Rizzieri DA, et al. Among authors: ibom vk. Clin Cancer Res. 2003 Feb;9(2):663-8. Clin Cancer Res. 2003. PMID: 12576433 Clinical Trial.

Rituximab in lymphocyte predominance Hodgkin's disease: a case series.

Ibom VK, Prosnitz RG, Gong JZ, Moore JO, DeCastro CM, Prosnitz LR, Rizzieri DA, Gockerman JP. Ibom VK, et al. Clin Lymphoma. 2003 Sep;4(2):115-8. doi: 10.3816/clm.2003.n.021. Clin Lymphoma. 2003. PMID: 14556684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters